Site #120 — Dallas, Texas

Site #120 is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Site #120 has participated in 1 clinical trials.

Therapeutic areas: Chemotherapy-induced Peripheral Neuropathy.

Sponsors: Veloxis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #120?

Site #120 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #120 conducted?

Site #120 has 1 clinical trials on record. Their work covers Chemotherapy-induced Peripheral Neuropathy.

Is Site #120 accredited by Crixeo Health?

Site #120 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #120?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.